Seer, Inc. (California) (SEER)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
Oct 16, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Seer EPS Diluted (Quarterly) : -0.3063 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3063 |
| March 31, 2026 | -0.3007 |
| December 31, 2025 | -0.2855 |
| September 30, 2025 | -0.3238 |
| June 30, 2025 | -0.3344 |
| March 31, 2025 | -0.3358 |
| December 31, 2024 | -0.3679 |
| September 30, 2024 | -0.3486 |
| June 30, 2024 | -0.3538 |
| March 31, 2024 | -0.3202 |
| December 31, 2023 | -0.2774 |
| September 30, 2023 | -0.3299 |
| June 30, 2023 | -0.3675 |
| March 31, 2023 | -0.377 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.3587 |
| September 30, 2022 | -0.3834 |
| June 30, 2022 | -0.3658 |
| March 31, 2022 | -0.3814 |
| December 31, 2021 | -0.3206 |
| September 30, 2021 | -0.3007 |
| June 30, 2021 | -0.2731 |
| March 31, 2021 | -0.2743 |
| December 31, 2020 | -0.2124 |
| September 30, 2020 | -0.1351 |
| June 30, 2020 | -0.1004 |
| March 31, 2020 | -0.0902 |
| December 31, 2019 | -0.0845 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Champions Oncology, Inc. | -0.0306 |
| Medpace Holdings, Inc. | 4.250 |
| Avantor, Inc. | 0.0563 |
| Personalis, Inc. | -0.3005 |
| Adaptive Biotechnologies Corp. | -0.2489 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.90M |
| Revenue (Quarterly) | 3.102M |
| Total Expenses (Quarterly) | 20.00M |
| Enterprise Value | -17.65M |
| Gross Profit Margin (Quarterly) | 48.55% |
| Profit Margin (Quarterly) | -544.8% |
| Earnings Yield | -59.92% |
| Normalized Earnings Yield | -59.92 |